ask our doctors

Amenorrhea Primary

Get the facts on Amenorrhea Primary treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Amenorrhea Primary prevention, screening, research, statistics and other Amenorrhea Primary related topics. We answer all your qestions about Amenorrhea Primary.

Question: Can doctors prescribe the birth control pill for women with primary amenorrhea? I'm 17 and I've never had a period, so I'm in the primary amenorrhea category. Thing is, I'm getting worried about it and I've been to the doctors (they've already run blood tests and now they're going to send me to a gyno) but what I was wondering was could they prescribe the pill for me to 'kick start' my periods? Are there any instances in where the pill is used to stop amenorrhea? Please help!

Answer: Those are questions you need to ask your gynecologist when you go. Make a list and make sure all your questions are answered.


Amenorrhea Primary News

Clinical Psychiatry News Digital Network

Metformin Resolves Amenorrhea in Antipsychotic-Treated Schizophrenia
Clinical Psychiatry News Digital Network
 

Dainippon Sumitomo Pharma Reports that Latuda® (lurasidone HCl) Met Primary ...

PharmiWeb.com (press release)
?ÄúWe believe these data show LATUDA may help patients with bipolar I depression,?Äù said Masayo Tada, Representative Director, President and Chief Executive Officer, Dainippon Sumitomo Pharma Co., Ltd. ?ÄúWith both studies meeting their primary ...
 

New Study Shows Patients Can Effectively be Switched to Latuda(R) (lurasidone ...

MarketWatch (press release)
The study's primary endpoint was time to treatment failure (defined as discontinuation due to insufficient clinical response or an adverse event, including exacerbation of underlying disease). In addition, the study was intended to assess the safety ...
 

Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing ...

EON: Enhanced Online News (press release)
In this study 1 , both LATUDA doses demonstrated statistically significant improvement at the Week 6 study endpoint compared to placebo in change from baseline in Positive and Negative Syndrome Scale total score (PANSS, primary efficacy endpoint) and ...